|
Jan 12
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Jan 11
|
Biotech Stock Roundup: REGN Down on Eylea Update, MRNA Gains on Preliminary Results
|
|
Jan 10
|
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
|
|
Jan 10
|
Investors in Moderna (NASDAQ:MRNA) have seen enviable returns of 578% over the past five years
|